Poorly Cross-Linked Peptidoglycan in MRSA Due to mecA Induction Activates the Inflammasome and Exacerbates...

Area of Science:

• Microbiology
• Immunology
• Molecular Biology

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) causes severe infections with unclear pathogenicity mechanisms.
• Penicillin-binding protein 2A (PBP2A), encoded by the mecA gene, confers β-lactam resistance in MRSA.

Purpose of the Study:

• To elucidate the role of mecA and its encoded protein, PBP2A, in MRSA pathogenicity.
• To investigate the impact of mecA expression on host immune responses during MRSA infection.

Main Methods:

• Analyzing the effect of mecA induction on MRSA peptidoglycan structure.
• Assessing IL-1β production and NLRP3 inflammasome activation in macrophages exposed to MRSA.
• Evaluating MRSA-induced pathology in vivo following β-lactam treatment.

Main Results:

• MecA induction reduces peptidoglycan cross-linking, enhancing bacterial degradation by phagocytes and promoting IL-1β production.
• Peptidoglycan from β-lactam-challenged MRSA activates the NLRP3 inflammasome in macrophages.
• Mutant MRSA with reduced peptidoglycan cross-linking exhibit increased IL-1β production and in vivo pathology.
• β-lactam treatment of MRSA skin infections exacerbates IL-1-dependent immunopathology.

Conclusions:

• The mecA gene product, PBP2A, directly contributes to MRSA pathogenicity by altering peptidoglycan structure.
• Antibiotic-induced mecA expression during MRSA infection leads to increased immunopathology via altered peptidoglycan and subsequent IL-1β production.